Filter
8012
Filtered Results: 8012
Text search:
use
of
medicines
Featured
Recommendations
738
New Publications
1908
Language
Document type
No document type
4176
Studies & Reports
1514
Guidelines
1094
Manuals
447
Strategic & Response Plan
276
Fact sheets
187
Training Material
152
Situation Updates
63
Brochures
31
Resource Platforms
31
Infographics
19
Online Courses
15
Videos
4
App
3
Countries / Regions
India
371
Global
339
Kenya
221
South Africa
190
Ethiopia
160
Uganda
151
Western and Central Europe
142
Nepal
138
Sierra Leone
138
Africa
136
Nigeria
135
Tanzania
123
Liberia
120
Malawi
117
Latin America and the Carribbean
117
Bangladesh
108
Zambia
102
Myanmar / Burma
95
Ukraine
91
Ghana
90
Rwanda
83
Syria
80
Namibia
69
Philippines
65
Congo, Democratic Republic of
62
Eastern Europe
59
Zimbabwe
53
South–East Asia Region
53
Russia
51
Brazil
49
Mozambique
44
Asia
43
West and Central Africa
41
East and Southern Africa
41
Lesotho
40
Senegal
36
Guinea
36
Cambodia
36
Middle East and North Africa
36
Indonesia
35
Burkina Faso
34
Germany
34
South Sudan
33
Haiti
31
Cameroon
29
Venezuela
29
Eastern Europe and Central Asia
27
Botswana
27
Yemen
26
Eswatini/ Swaziland
20
Benin
19
Colombia
18
USA
18
Sudan
18
Afghanistan
17
Vietnam
17
Pakistan
17
Thailand
16
Peru
16
Lebanon
15
Madagascar
15
Mali
14
China
13
Jordan
13
Moldova
13
Western Pacific Region
12
Sri Lanka
12
Paraguay
11
North America
11
Somalia
11
Tajikistan
10
Georgia
10
Central African Republic
10
Albania
9
Ecuador
9
North Macedonia
8
Mexico
8
Laos
8
United Kingdom
8
Côte d’Ivoire / Ivory Coast
8
Kyrgyzstan
7
Spain
7
Southern Africa
7
Bolivia
7
Angola
7
Iraq
7
Turkey
6
Chile
6
Argentina
6
Egypt
6
Palestine
6
El Salvador
5
Kazakhstan
5
Iran
5
Niger
5
Jamaica
5
Belarus
5
Papua New Guinea
5
Poland
5
Chad
5
Libya
5
Timor Leste/ East Timor
4
Canada
4
Estonia
4
Burundi
4
Morocco
4
Guinea-Bissau
4
Hungary
4
Saudi Arabia
4
Portugal
4
Bhutan
4
Guatemala
4
Serbia
3
Gambia
3
Fiji
3
Malaysia
3
Qatar
3
Armenia
3
Turkmenistan
3
Japan
3
France
3
Mauritius
3
Tunisia
3
Nicaragua
3
Romania
3
Congo-Brazzaville
2
Uzbekistan
2
Mongolia
2
Bulgaria
2
Mauritania
2
Lithuania
2
Gabon
2
South Korea
2
Israel
2
Bosnia and Herzegovina
2
Greece
2
Honduras
2
Switzerland
1
Australia
1
Togo
1
Singapore
1
Italy
1
Dominican Republic
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Djibouti
1
Slovakia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2871
Clinical Guidelines
643
Public Health
457
Women & Child Health
370
Key Resources
322
Capacity Building
167
Pharmacy & Technologies
94
Annual Report MEDBOX
3
Toolboxes
COVID-19
697
Mental Health
691
HIV
645
TB
438
AMR
351
NTDs
284
Caregiver
245
Disability
236
Pharmacy
232
Planetary Health
224
NCDs
224
Ebola & Marburg
199
Rapid Response
187
Conflict
170
Refugee
135
Global Health Education
117
Malaria
106
Health Financing Toolbox
87
Natural Hazards
74
Zika
50
Specific Hazards
40
Social Ethics
38
Cholera
25
Polio
22
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
As we approach World Asthma Day on the May 2, 2023, we reflect on the theme “ Asthma Care for All”. Prevalence of Asthma is increasing amongst children, adolescents and adults. Under-diagnosis, underutilization of inhaled corticosteroids, inaccessibility of treatment, and unaffordability of medi...
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order ...
Manual for use in primary care.
There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural relevance for substances other than alcohol or tobacco,...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
This guide can inform any partner that manages or supports public health supply chains. Ministries of health, technical assistance partners, or non-governmental organization (NGO) operating distribution systems can all benefit from conducting a costing exercise and can use the material presented in ...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
When an infection strikes, and medicines like antibiotics (and other antimicrobials) do not work, you can lose your entire stock of animals to disease. This also puts the health of you and your family at risk when the infection can spread between animals and people. Save lives and livelihoods by fol...
Cogent Medicine, 7:1, 1794272,
PUBLIC HEALTH & PRIMARY CARE | RESEARCH ARTICLE
Edutainment and infographics for
schistosomiasis health education in Ndumo area,
Kwazulu-Natal, South Africa
Tafadzwa Mindu1*, Muhubiri Kabuyaya1 and Moses J. Chimbari1
Educational interventions targeting communiti...
To test for ethnic discrimination in access to outpatient health care services, we carry out
an email-correspondence study in Germany. We approach 3,224 physician offices in the 79
largest cities in Germany with fictitious appointment requests and randomized patients’
characteristics. We find t...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Updated 20 Nov. 2020
Countries can use this checklist of hospital governance, structures, plans and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that require investment and action for the development of h...
WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended
The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing ...
2nd edition. The purpose of this document is to provide a generic model that can be used for risk assessment of larviciding and mollusciciding; it aims to harmonize the risk assessment of such pesticides for public health use. The assessment considers both adults and children (all age groups) as we...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Session V: Regulatory & quality assurance aspects
Update on prequalification of ARVs and regional harmonisation of medicine registration
Deusdedit K. Mubangizi
Group Lead, Inspections, WHO-PQT E-mail: mubangizid@who.int
Acknowledgements:
• Matthias Stahl
• Milan Smid
• Antony Fake
...
The purpose of this Guide is to set out a simple, user-friendly, step-by-step approach for conducting table-top exercises for use in countries. These are generic guidelines which may be adapted for use at all levels in a country.
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
